Ilya Makarovskiy
Foot & Ankle Surgery · New York, NYNPI 1326443771
Payments from drug & device makers
Across 15 payments — averaging $297.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gotham Surgical Solutions & Devices, Inc.$2K
- Paragon 28, Inc.$2K
- Advanced Oxygen Therapy Inc.$186
- Bone Support Inc.$67
- Polynovo North America LLC$40
- Nevro Corp.$30
- plus $39 from 2 others
What the payments were for
- Travel & lodging$57813%
- Food & beverage$1,48233%
- Education$2,40054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gotham Surgical Solutions & Devices, Inc. | 3 | $2,433 |
| Paragon 28, Inc. | 3 | $1,665 |
| Advanced Oxygen Therapy Inc. | 4 | $186 |
| Bone Support Inc. | 1 | $67 |
| Polynovo North America LLC | 1 | $40 |
| Nevro Corp. | 1 | $30 |
| Axogen | 1 | $22 |
| Smith+Nephew | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,460 in reported general payments places this provider in the 65th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 19 | $8,894 |
| Diclofenac Sodium | 29 | $4,249 |
| Ciclopirox | 72 | $2,261 |
| CiclopiroxCiclopirox Olamine | 30 | $1,149 |
| Ammonium Lactate | 76 | $1,035 |
| Naproxen | 11 | $516 |
| Cephalexin | 17 | $295 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $160 |
| Doxycycline Hyclate | 12 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $17 | $8,89419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in New York
- Jonathan DelandNew York$4.1M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$644K
- John KennedyNew York$613K
- Stuart MogulNew York$131K
- Deena HornNew York$93K
- John DoolanNew York$87K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.